Top 20 Most Popular Stocks Among Financial Advisors This Week

Finally, Gilead Sciences, Inc. (NASDAQ:GILD) is the most popular biotech stock. It has gained 13% since the beginning of the year. With the biotech industry being hot at the moment, a lot of stocks have surged and entered overvalued territory (the mean industry P/E stands at 35.5). Gilead Sciences, Inc. (NASDAQ:GILD) is an exception, as it is still trading at just 8.5-times forward earnings, even though the company has reported earnings above estimates for the past few quarters. Gilead Sciences, Inc. (NASDAQ:GILD) is the favorite biotech stock among the funds from our database as well, with 90 funds owning shares at the end of September, including D. E. Shaw and Cliff Asness’ AQR Capital Management, which hold 6.15 million shares and 4.77 million shares, respectively.

Apple Inc. (NASDAQ:AAPL) has always been surrounded by a lot of attention and it currently ranks as the most-searched stock among financial advisors. The company’s stock has recently taken a hit after a report by Credit Suisse cut its forecast on iPhone sales based on a decline in supply chain orders. Over the months there have been many reports that suggested weakening sales for Apple Inc. (NASDAQ:AAPL), but the company has managed to negate these concerns in its financial reports, so we’ll see if the same holds true in this case as well. Apple Inc. (NASDAQ:AAPL) ranked as the second-most popular stock among the investors we follow, even though there were 11 less of them at the end of the third quarter as there were at the start, at 133.

Disclosure: None